Arca Biopharma Inc.





After Hours:




Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

Stock Price
Open: 0.52
Prev. Close: 0.52
Low/Hi: 0.51 - 0.55
52-Week: 0.45 - 2.00
Equity: 539,534
90-Day Avg: 815,360
Todays Stock Vol: 74.5
20-Day (HV): 62.5
52-Week (HV): 106.3
Div. Yield:
Earnings: 12-Nov (Est.)
P/E Ratio:
Market Cap: 7.3 M
Short Int Pct: 0.0%
Pct Held By Inst.: 10.1%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

About ABIO

ARCA biopharma, Inc is a biopharmaceutical company principally focused on developing genetically-targeted therapies for cardiovascular diseases. The company's lead product candidate, Gencaroâ„¢ (bucindolol hydrochloride), is a pharmacologically unique beta-blocker and mild vasodilator that is in a clinical trial for the treatment of atrial fibrillation, or AF, in patients with heart failure and left ventricular systolic dysfunction, or HFREF.
Primary Exchange: NASDAQ
SIC In Vitro & In Vivo Diagnostic Substances
NAICS In-Vitro Diagnostic Substance Manufacturing

ABIO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 16.1 B 1.61062E+10 3,418 3418 0.0% 0 455 455
WMCR Invesco Wilshire Micro-Cap ETF 30.1 M 3.01E+07 991 991 0.01% 6E-05 2 K 1805

Wait, Before You Leave...